Credits: NBC
Melanie Watson, Diff'rent Strokes actress and disability advocate dies at 57 on Friday, December 26. The news was confirmed by her brother Robert, and told that she was hospitalized prior to her death. While her cause of death has not been revealed yet, her brother said that she was in hospital due to some bleeding issue.
Melanie was born with osteogenesis imperfecta or OI, which the Johns Hopkins Medicine notes is an inherited (genetic) bone disorder that is present at birth. It is also known as brittle bone disease. A child born with OI may have soft bones that break or fracture easily, bones that are not formed normally and other problems Signs and symptoms may range from mild to severe.
OI also have eight different forms and the types vary greatly both within and between types. As per the Johns Hopkins Medicine, here are the eight types of OI:
Type I. Mildest and most common type. About 50% of all affected children have this type. There are few fractures and deformities
Type II. Most severe type. A baby has very short arms and legs, a small chest, and soft skull. He or she may be born with fractured bones. He or she may also have a low birth weight and lungs that are not well developed. A baby with type II OI usually dies within weeks of birth
Type III. Most severe type in babies who don’t die as newborns. At birth, a baby may have slightly shorter arms and legs than normal and arm, leg, and rib fractures. A baby may also have a larger than normal head, a triangle-shaped face, a deformed chest and spine, and breathing and swallowing problems. These symptoms are different in each baby.
Type IV. Symptoms are between mild and severe. A baby with type IV may be diagnosed at birth. He or she may not have any fractures until crawling or walking. The bones of the arms and legs may not be straight. He or she may not grow normally.
Type V. Similar to type IV. Symptoms may be medium to severe. It is common to have enlarged thickened areas (hypertrophic calluses) in the areas where large bones are fractured
Type VI. Very rare. Symptoms are medium. Similar to type IV.
Type VII. May be like type IV or type II. It is common to have shorter than normal height. Also common to have shorter than normal upper arm and thighbones.
Type VIII. Similar to types II and III. Very soft bones and severe growth problems.
This is a disease that could be passed on through genes and there are different types that could be passed on in different ways. These genes could be inherited from one or both parents, or could be passed on from an unexplained change or a mutation of the gene.
Most babies who have OI have a defect of one of two genes. These genes help in collagen forming, which is a main part of connective tissue that connects and supports the whole body, including bones. Because of a certain defect, there is no enough collages, or the collagen is abnormal, which causes this disease.
The main aim of treatment for this disease lies in prevention of deformities and fractures.
Credits: iStock
15 US states sued President Donald Trump led administration after the Department of Health and Human Services led by Health Secretary Robert F Kennedy Jr. revised vaccine schedule that led to coverage fall from 17 to 11 diseases for children. These 15 states are led Democrats and on Tuesday, they announced suing the Trump administration over unscientific grounds of releasing a new vaccine schedule.
The lawsuit has been filed by a coalition of 14 attorneys general and the governor of Pennsylvania. They have asked the courts to nullify the administration's decision to reduce the number of diseases children are routinely immunized from 17 to 11.
The lawsuit also challenges "the unlawful replacement" of members of the federal Advisory Committee on Immunization Practices, who recommend vaccines for Americans. The lawsuit names the Department of Health and Human Services and Health Secretary Robert F Kennedy Jr as defendants. It also names the Centers for Disease Control and Prevention and its acting director, Dr Jay Bhattacharya.
Read: CDC Vaccine Schedule: Coverage Falls From 17 to 11 Diseases For Children
In a news briefing on Tuesday, Rob Bonta, attorney general of California said, "H.H.S. Secretary R.F.K. Jr. and his C.D.C. are flouting decades of scientific research, ignoring credible medical experts, and threatening to strain state resources and make America’s children sicker.” Bonta continued, "The fact is, vaccines save lives and save our state’s money."
The lawsuit also notes that the administration's revised vaccination schedule was unscientific and relied instead on comparisons to countries that are different than the United States.
Kris Mayes, attorney general of Arizona, as reported by The New York Times said that the latest vaccine schedule "copies" Denmark's recommendation, where the country already has a nationalized health care and the population is fraction of that of the US. "Copying Denmark’s vaccine schedule without copying Denmark’s health care system doesn’t give families more options — it just leaves kids unprotected from serious diseases."
Also Read: Wegovy And Ozempic Will Cost Less In 2027, Novo Nordisk Slashes Weight Loss Drugs Prices By Half

On January 5, 2026, the federal health officials led by RFK Jr. announced that the new Centers for Disease Control and Prevention (CDC), vaccine schedule will include routine shots for 11 diseases for children. This is down from 17 diseases, which were earlier included.
Under the revised schedule, vaccines for a limited number of diseases remain universally recommended for children. These include protection against measles, polio, and whooping cough, which are still considered essential routine immunizations.
The most controversial change is the narrowing of recommendations for several common childhood vaccines. Immunization against the following illnesses is now advised only for high-risk children or after consultation with a health care provider:
Covid-19 vaccination has also shifted to a consultation-based recommendation rather than routine use for all children.
This means shots that were once automatically given at set ages, including at birth, during infancy, and in adolescence, may now depend on individual medical discussions rather than standard guidance.
Credits: iStock
Wegovy and Ozempic will cost less by January 1 of 2027 as manufacturer Novo Nordisk announced that the prices will be cut in half. The manufacturer said that the popular GLP-1 weight loss drugs will be as much as 50 per cent.
The manufacturer noted that this cut applies to all doses and the semaglutide tablet Rybelsus will now cost $675 a month. Rybelsus has been approved by the US Food and Drug Administration (FDA) to reduce the risk of heart attacks in those with diabetes.
Read: Doctor Explains Why Weight Loss Drugs Like Ozempic Are Truly A Medical Breakthrough
In a statement to PEOPLE, Jamey Millar, Executive Vice President, US Operations of Novo Nordisk Inc. said, "There are more than 100 million people living with obesity and over 35 million with type 2 diabetes and, for some, list price has been a real barrier to access and affordability."
Wegovy injections and pills currently cost $1,349.02 a month, whereas Ozempic and Rybelus cost $1,027.51. These figures have been emailed to PEOPLE by Novo Nordisk.
Read: GLP-1 Drugs Don’t Just Curb Appetite; They Rewire the Brain, Shows Study
People with commercial insurance pay $25 a month, whereas those using cash pay between $149 to $499. Patients on Medicare will pay $274 per month.

GLP-1 drugs mimic the action of the natural hormone GLP-1 to regulate blood sugar and promote weight loss. They work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake.
Read: Zepbound Outperforms Other Weight Loss Drugs, More Details Inside
In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate pancreas to release insulin and suppress the release of another hormone called glucagon.
These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.
In September 2025, WHO added GLP-1 drugs to its list of essential medicines, but only for treating diabetes, not for obesity alone. The new guideline extends that conversation, offering a more formal stance on their use in obesity management. The recommendations were developed by a committee of experts in obesity, pharmacology, and public health, following requests from several WHO member states. They also align with approvals already granted by regulators like the US FDA.
Credits: iStock
HPV Vaccine: India is planning to launch a free nationwide HPV or the Human Papillomavirus vaccination program to strengthen women's health and eliminate preventable cervical cancers in the country. Health and Me has also reported on the same. Government has also urged parents and guardians to come forward and ensure that their 14-year-old daughters are vaccinated against HPV.
Read: India to Soon Launch Free HPV Vaccine For Young Girls To Prevent Cervical Cancer
Dr Asmita Dongare, a Pune-based consultant obstetrician and gynecologist writes on her website that cervical cancer is still one of the top causes of cancer-related deaths among Indian women. This is why every young woman must consider to get the vaccine, especially when the drive allows them to avail it for free.
HPV vaccination also provides up to 90 per cent protection against cervical cancer when administer before exposure. Studies have also shown that the vaccine is 97 per cent effective in preventing cervical cancer and related cell changes if given before the virus exposure.
Furthermore, the vaccine could prevent more than one type of cancer, notes the doctor, which includes:
The vaccines have also shown to provide long-term protection with individuals monitored for at least 12 years who showed no evidence of weakened immunity. The vaccine creates antibodies and provide lasting protection against the virus.
Also Read: 15 States Sue Trump Administration Over Revised Vaccine Schedule
The vaccine is most effective when it is administered before exposure to HPV and before becoming sexually active. Young women aged 9 to 14 years show vaccine effectiveness of 74 to 93 per cent and this decreases with age.
The nationwide program, based on expert recommendations of the National Technical Advisory Group on Immunization (NTAGI), will target girls aged 14 years.
At 14, the HPV vaccine offers maximum preventive benefit, well before potential exposure to the virus.
"By prioritising prevention at the right age, the program is expected to provide lifelong protection and significantly reduce the future burden of cervical cancer in the country," the sources said.
Vaccination under the national program will be voluntary and free of cost.
The HPV vaccination will be conducted exclusively at designated government health facilities, including Ayushman Arogya Mandirs (Primary Health Centres), Community Health Centres, Sub-District and District Hospitals, and Government Medical Colleges.
The vaccine to be used is non-live and does not cause HPV infection. It is supported by more than 500 million doses administered globally since its introduction in 2006.
"India’s national program will use Gardasil, a quadrivalent HPV vaccine that protects against HPV types 16 and 18, which cause cervical cancer, as well as types 6 and 11. Strong global and Indian scientific evidence confirms that a single dose provides robust and durable protection when administered to girls in the recommended age group," the sources said.
© 2024 Bennett, Coleman & Company Limited